thoracoscopic surgery
Conditions
Interventions
Group A: programmed intermittent infusion of 0.75% ropivacaine 15ml on pleural cavity
Group B:programmed intermittent infusion of normal saline 15ml on pleural cavity
Sponsors
The First Affiliated Hospital of Wenzhou Medical University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Eligible subjects aged 18 years or older, ASA I to III, and scheduled for thoracoscopic surgery
Exclusion criteria
Exclusion criteria: Exclusion of amide local anesthetic allergies or allergic to opioids, chronic pain, severe central neurologic diseases,patients with liver and renal insufficiency,history of alcohol and opioid dependence, the recent use of opioid drugs or drugs interaction with ropivacaine, inability to carry out VAS test,patient who was younger than 12 years old,patients with BMI=30kg/m2 or =15kg/m2.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain score when coughing at different time points after operation;Pain score when deep breathing after operation at different time points after operation;Pain score on natural breath at different time points after operation; | — |
Secondary
| Measure | Time frame |
|---|---|
| Dose of administration of pleural cavity at different time points after operation;morphine consumption at different time points after operation;extra analgesic consumption;Patient’s satisfaction; | — |
Countries
China
Contacts
Public ContactXuzhong Xu
The First Affiliated Hospital of Wenzhou Medical University
Outcome results
None listed